Q2 2023 Holdings
Filed 2023-08-14 | 70 holdings | $286.3M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2023-08-21) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $21.4M | 92,500 | 7.5% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $17.5M | 550,000 | 6.1% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $14.5M | 211,608 | 5.1% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $12.3M | 321,017 | 4.3% |
| Madrigal Pharmaceuticals Inc(MDGL)Call | COM | 558868105 | $12.3M | 53,100 | 4.3% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $12.0M | 1,600,000 | 4.2% |
| Morphic Hldg Inc | COM | 61775R105 | $11.6M | 201,887 | 4.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $11.5M | 1,050,118 | 4.0% |
| Biogen Inc(BIIB) | COM | 09062X103 | $11.4M | 40,000 | 4.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $9.6M | 910,317 | 3.4% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $9.5M | 447,667 | 3.3% |
| Bridgebio Pharma Inc | NOTE 2.500% 3/1 | 10806XAB8 | $9.5M | $12,000,000 | 3.3% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $7.2M | 226,275 | 2.5% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $6.8M | 100,000 | 2.4% |
| Bridgebio Pharma Inc(BBIO)Put | COM | 10806X102 | $6.5M | 376,000 | 2.3% |
| Viking Therapeutics Inc(VKTX)Put | COM | 92686J106 | $5.7M | 350,000 | 2.0% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $5.6M | 900,723 | 1.9% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $5.4M | 650,875 | 1.9% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $5.2M | 57,760 | 1.8% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $4.9M | 260,000 | 1.7% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $4.9M | 300,000 | 1.7% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $4.3M | 60,000 | 1.5% |
| Inozyme Pharma Inc | COM | 45790W108 | $4.2M | 751,796 | 1.5% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $4.1M | 125,148 | 1.4% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $3.8M | 1,589,017 | 1.3% |
| Immatics N.v(IMTX) | SHS | N44445109 | $3.5M | 300,000 | 1.2% |
| Esperion Therapeutics Inc NE | NOTE 4.000%11/1 | 29664WAB1 | $3.4M | $6,925,000 | 1.2% |
| Springworks Therapeutics Inc | COM | 85205L107 | $3.4M | 130,000 | 1.2% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $3.3M | 100,696 | 1.2% |
| Viridian Therapeutics Inc(VRDN)Call | COM | 92790C104 | $3.1M | 130,400 | 1.1% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $3.0M | 29,105 | 1.0% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $3.0M | 87,031 | 1.0% |
| Fibrogen Inc(FGENEUR)Put | COM | 31572Q808 | $2.7M | 983,300 | 0.9% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $2.7M | 983,300 | 0.9% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $2.3M | 60,376 | 0.8% |
| Theseus Pharmaceuticals Inc | COM | 88369M101 | $2.2M | 240,244 | 0.8% |
| Aeglea Biotherapeutics Inc(AGLEUSD) | COM | 00773J103 | $2.2M | 4,900,000 | 0.8% |
| Vincerx Pharma Inc | COM NEW | 92731L106 | $1.9M | 1,492,771 | 0.7% |
| Lianbio | SPONSORED ADS | 53000N108 | $1.8M | 800,676 | 0.6% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $1.6M | 125,000 | 0.6% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $1.6M | 178,292 | 0.6% |
| Precigen Inc | NOTE 3.500% 7/0 | 46122TAA0 | $1.5M | $1,500,000 | 0.5% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $1.3M | 600,000 | 0.5% |
| Aadi Bioscience Inc(WHWK) | COM | 00032Q104 | $1.3M | 187,675 | 0.4% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $1.3M | 150,000 | 0.4% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $1.2M | 118,891 | 0.4% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $1.2M | 100,000 | 0.4% |
| Aravive Inc(VSAREUR)Put | COM | 03890D108 | $1.1M | 861,200 | 0.4% |
| Inflarx NV(IFRX) | COM | N44821101 | $1.1M | 240,200 | 0.4% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $1.1M | 62,500 | 0.4% |